Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

PharmSource ranks Patheon as top global contract development and manufacturing organization

Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it has been ranked as a top global contract development and manufacturing organization. PharmSource(R), a respected independent pharmaceutical research organization, recently published a study looking at the number of FDA new drug approvals (NDAs and BLAs) which were outsourced by sponsor companies and subsequently launched.

15 Jul 2010

Watson Pharmaceuticals signs exclusive, worldwide licensing agreement with Itero Biopharmaceuticals

Watson Pharmaceuticals, Inc. today announced an exclusive, worldwide licensing agreement with Itero Biopharmaceuticals, Inc., a venture-backed specialty biopharmaceutical company, to develop and commercialize Itero's Recombinant Follicle Stimulating Hormone. The product is currently in preclinical development as a biosimilar molecule for the treatment of female infertility.

15 Jul 2010

Biomagnetics Diagnostics reports positive test results of unique PVA film formulation

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the results of recent testing of the unique PVA film formulation produced by Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. Earlier this week, Biomagnetics announced its intent to acquire Lanzhou as the first of several planned acquisitions to be done at a $1.00 share price valuation for Biomagnetics Diagnostics' common shares.

15 Jul 2010

First 1M doses of smallpox vaccine for immune-compromised populations delivered

Delivery to the Strategic National Stockpile of the first 1 million doses of the nation's first smallpox vaccine for certain immune-compromised populations is now complete, the result of a Project BioShield contract.

15 Jul 2010

Merck acquires Millipore for $7.0 billion

Merck KGaA, a global pharmaceutical and chemical company, today announced the successful completion of its acquisition of Millipore Corporation, a leading Life Science company based in Billerica, Massachusetts, USA, for an aggregate purchase price including debt and cash of approximately $7.0 billion. Merck agreed to acquire Millipore on February 28, 2010 for $107 in cash per share of Millipore common stock.

15 Jul 2010

Concert Medical releases 'Conductor' family of Interventional Coronary Guidewires in U.S.

Concert Medical, LLC today announced the launch of the "Conductor™" family of Interventional Coronary Guidewires to the U.S. market. These guidewires are designed to address an extensive range of coronary disease cases at a superior value. The FDA granted Concert Medical clearance for the use and sale in the U.S. of the Conductor product line in September 2009.

15 Jul 2010

CardioGenics Holdings' subsidiary signs second product agreement with Merck Chimie

CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care Point-Of-Care analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced that the Company's subsidiary, CardioGenics Inc., has entered into an agreement with Merck Chimie S.A.S. to adopt its proprietary biological-linking technology to Merck-supplied magnetic beads designed to increase yields in antibody manufacturing.

15 Jul 2010

OSI Electronics receives $4 million order from innovative medical device manufacturer

OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that OSI Electronics, a business within its Optoelectronic and Manufacturing division, has received an order of approximately $4 million for electronic sub-assemblies from an innovative medical device manufacturer.

14 Jul 2010

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.

14 Jul 2010

WL Ross and Mac Crawford announce joint venture to co-invest in and restructure healthcare companies

Wilbur L. Ross, Jr., CEO of WL Ross & Co. LLC, and Edwin "Mac" Crawford announced today a joint venture, Crawford-Ross, to co-invest in and restructure healthcare companies. Mr. Ross said, "We are prepared to invest more than $1 billion to support Mac and his team as we jointly build a major position in healthcare."

14 Jul 2010

Microtest white paper guides medical device manufacturers in applying new FDA regulations to combination products

A new free, white paper that guides medical device manufacturers in the complicated process of applying new U.S. Food and Drug Administration (FDA) regulations to combination products embedded with pharmaceutical or biologic components is now available from Microtest Laboratories (http://www.microtestlabs.com/combination-products-20/)

14 Jul 2010

Neptune first-quarter 2010 revenue up by 45% to $4,162,000

Neptune Technologies & Bioressources Inc. today reports its consolidated financial results for the three-month period ended May 31, 2010, appoints IR firm and updates on options and warrants.

14 Jul 2010

Invida Group, Amdipharm partner to promote proprietary products in key Asian markets

Invida Group Pte Ltd, the leading specialty biopharmaceutical company focused on the commercialization of healthcare products throughout Asia Pacific, today announced that it has entered into an agreement with Amdipharm for the licensing and commercialization of its proprietary products throughout Asia. Under this agreement, Invida will leverage its full suite of capabilities to bring Amdipharm's products to market, from regulatory approval and licensing, through packaging and supply chain optimization, to commercialization, sales, and marketing.

14 Jul 2010

CTI signs agreement with NerPharMa for long-term manufacture of pixantrone

Cell Therapeutics today announced that it has signed a manufacturing agreement with NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences S.r.l. for CTI's drug candidate pixantrone.

14 Jul 2010

Emergent awarded $107M HHS BARDA contract to develop large-scale manufacturing of BioThrax

Emergent BioSolutions Inc. announced today that it has signed a contract valued at up to $107 million with the Office of the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (HHS), to develop and obtain regulatory approval for large-scale manufacturing of BioThrax® (Anthrax Vaccine Adsorbed) in Building 55. Building 55 is the company's large-scale state-of-the-art vaccine manufacturing facility in Lansing, Michigan.

14 Jul 2010

Baxter to provide transition guide for facilities using Colleague infusion pumps

The U.S. Food and Drug Administration today required Baxter Healthcare Corp. to take specific steps to carry out the April 2010 recall of all Colleague Volumetric Infusion Pumps (CVIP) and to provide customers with a refund, a replacement pump, or lease termination.

14 Jul 2010

Cepheid denies Abaxis' allegations of patent infringement, files answer and counterclaims

Cepheid announced today that it has filed an answer and counterclaims in a patent suit brought by Abaxis on June 28, 2010 in the United States District Court for the Northern District of California. In its filing, Cepheid denied Abaxis' allegations of patent infringement, asked the Court to determine it has paid all royalties due and is in full compliance with all the terms of its license, and to find that Abaxis' patents are invalid.

13 Jul 2010

Encap Drug Delivery granted patents in US, Europe for DuoCap capsule delivery system

Encap Drug Delivery, a leading provider of development and manufacturing services to the pharmaceutical industry, has received confirmation that their DuoCap™, capsule delivery system has been granted patents for US and Europe.

13 Jul 2010

Sperian Respiratory Protection awarded VHA contract for 65,000 special configuration half-mask respirators

The U.S. Veterans Health Administration (VHA) has awarded Sperian Respiratory Protection USA a contract to purchase 65,000 special configuration modified Sperian Blue1 half-mask respirators with speaking diaphragm for use in VHA hospitals nationwide. VHA is the largest integrated healthcare system in the United States with over 150 hospitals and 130,000 healthcare workers. This award is a result of Sperian's emphasis on developing respiratory products that enhance speech intelligibility when worn by healthcare workers.

13 Jul 2010

Human Genome Sciences, Lonza announce commercial supply agreement for BENLYSTA

Human Genome Sciences, Inc. and Lonza today announced an agreement for the future commercial supply of BENLYSTA® (belimumab), which is currently under regulatory review in the United States and Europe as a potential new treatment for systemic lupus erythematosus (SLE). BENLYSTA is being developed by HGS and GlaxoSmithKline (GSK) under a co-development and commercialization agreement entered into in 2006.

13 Jul 2010

Manufacturing News and Research

Further Reading

PharmSource ranks Patheon as top global contract development and manufacturing organization

Watson Pharmaceuticals signs exclusive, worldwide licensing agreement with Itero Biopharmaceuticals

Biomagnetics Diagnostics reports positive test results of unique PVA film formulation

First 1M doses of smallpox vaccine for immune-compromised populations delivered

Merck acquires Millipore for $7.0 billion

Concert Medical releases 'Conductor' family of Interventional Coronary Guidewires in U.S.

CardioGenics Holdings' subsidiary signs second product agreement with Merck Chimie

OSI Electronics receives $4 million order from innovative medical device manufacturer

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

WL Ross and Mac Crawford announce joint venture to co-invest in and restructure healthcare companies

Microtest white paper guides medical device manufacturers in applying new FDA regulations to combination products

Neptune first-quarter 2010 revenue up by 45% to $4,162,000

Invida Group, Amdipharm partner to promote proprietary products in key Asian markets

CTI signs agreement with NerPharMa for long-term manufacture of pixantrone

Emergent awarded $107M HHS BARDA contract to develop large-scale manufacturing of BioThrax

Baxter to provide transition guide for facilities using Colleague infusion pumps

Cepheid denies Abaxis' allegations of patent infringement, files answer and counterclaims

Encap Drug Delivery granted patents in US, Europe for DuoCap capsule delivery system

Sperian Respiratory Protection awarded VHA contract for 65,000 special configuration half-mask respirators

Human Genome Sciences, Lonza announce commercial supply agreement for BENLYSTA

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy